Andrew M. Evens, DO, MBA, MSc

Andrew M. Evens, DO, MBA, MSc

Deputy Director of Clinical Services and Chief Physician Officer — Rutgers Cancer Institute

Dr. Evens is a hematologic oncologist specializing in Hodgkin and non-Hodgkin lymphoma, chronic lymphocytic leukemia, and cellular therapy, and is currently Chief Medical Officer and Oncology Lead for RWJBarnabas Medical Group. He earned his DO, MBA, and MSc and completed hematology/oncology fellowship at Northwestern University Feinberg School of Medicine. He has led more than 120 clinical trials and authored over 250 peer-reviewed manuscripts and 50 book chapters. His research has been continuously NIH-funded since 2005, and he serves as Editor-in-Chief of British Journal of Haematology and in national lymphoma research leadership roles.

Areas of Focus: Lymphoma, Hodgkin Lymphoma, CLL, Cellular Therapy, Clinical Trials

Latest Content